A glucose Monitor's second chance: can it tame type 1 diabetes in High-Risk teens?

NCT ID NCT07742306

Recruiting now Disease control Sponsor: Life for a Child Program, Diabetes Australia Source: ClinicalTrials.gov ↗

First seen Aug 03, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This pilot study tests whether intermittent use of a continuous glucose monitor (CGM), along with regular medical visits, diabetes education, and psychological support, can improve blood sugar control in children and adolescents with high-risk type 1 diabetes in the Dominican Republic. Forty participants aged 10 to 19 will use the Dexcom G7 CGM during two short monitoring periods, then return to usual finger-stick checks. The study will track changes in HbA1c, time in range, glucose variability, and diabetes-related distress to see if this combined approach helps.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Intermittent use of the Dexcom G7 continuous glucose monitor, combined with pediatric endocrinology follow-up, diabetes education, and psychological support
What this could lead to: If effective, this approach could offer a practical, resource-sensitive way to improve glucose control and reduce diabetes distress in high-risk youth, potentially informing broader care in similar settings.
What could go wrong: This is a small pilot study with only 40 participants, so results may not apply widely. The intermittent CGM use may not be enough to sustain improvements, and the added visits and support could be hard to maintain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES (T1D)

Contacts and locations

Locations

Fundación Aprendiendo a Vivir
RECRUITING

Santo Domingo, Dominican Republic
Hospital Infantil Regional Universitario Dr. Arturo Grullón
RECRUITING

Santiago de los Caballeros, Dominican Republic
Hospital Infantil Robert Reid Cabral
RECRUITING

Santo Domingo, Dominican Republic

More trials for these conditions

Other studies related to the condition(s) this trial covers.